Promises and perils of the FDA's over-the-counter naloxone reclassification

• David T. Zhu,
• Suzanne Tamang,
• Keith Humphreys

Affiliations

David T. Zhu

Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA; Corresponding author. Department of Social and Behavioral Sciences, Yale School of Public Health, 60 College Street, New Haven, CT, 06510, USA.

Suzanne Tamang

Program Evaluation Resource Center, Office of Mental Health and Suicide Prevention, Department of Veterans Affairs, Menlo Park, CA, USA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA

Keith Humphreys

Center for Innovation to Implementation, Veterans Affairs Health Care System, Palo Alto, CA, USA; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA